Tissue persistence of parvovirus B19 genotypes in asymptomatic persons

Parvovirus B19 (B19V) can persist in immunocompetent symptomatic and non‐symptomatic individuals, as demonstrated by the finding of viral DNA in different tissues, in absence of viremia and of anti‐B19V IgM. The spread and the nature of this phenomenon have not been clearly determined. In order to investigate the frequency of persistence and the tissue distribution of the three genotypes of B19V, the viral load of the persistent virus and its expression in the affected tissues, 139 tissue samples and 102 sera from 139 asymptomatic individuals have been analyzed by consensus PCRs and genotype specific PCRs for B19V detection and genotyping. Viral load was measured by real time PCR and viral mRNAs were detected by RT‐PCR. Altogether, 51% individuals carried B19V DNA, more frequently in solid tissues (65%) than in bone marrow (20%). Genotype 1 was found in 28% tissue samples, genotype 2 in 68% and genotype 3 in 3% only. Viral load ranged from less then 10 copies to 7 × 104 copies per 106 cells, with the exception of two samples of myocardium with about 106 copies per 106 cells. mRNA of capsid proteins was present in two bone marrow samples only. In conclusion, in asymptomatic individuals B19V persistence is more common in solid tissues than in bone marrow, and genotype 2 persists more frequently than genotype 1. The results suggest that the virus persists without replicating, at sub‐immunogenic levels. J. Med. Virol. 80:2005–2011, 2008. © 2008 Wiley‐Liss, Inc.

[1]  W. Poller,et al.  Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy , 2008, Journal of medical virology.

[2]  R. Tolba,et al.  Simultaneous persistence of multiple genome variants of human parvovirus B19. , 2008, The Journal of general virology.

[3]  A. Ekman,et al.  Biological and Immunological Relations among Human Parvovirus B19 Genotypes 1 to 3 , 2007, Journal of Virology.

[4]  S. Modrow,et al.  Human parvovirus B19 infection and antiphospholipid antibodies. , 2007, Autoimmunity reviews.

[5]  I. Ercan,et al.  Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease , 2007, Clinical and experimental dermatology.

[6]  K. Broliden,et al.  Clinical aspects of parvovirus B19 infection , 2006, Journal of internal medicine.

[7]  A. Vaheri,et al.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Brian D. Poole,et al.  Apoptosis of Liver-Derived Cells Induced by Parvovirus B19 Nonstructural Protein , 2006, Journal of Virology.

[9]  E. Sabino,et al.  Sequence Variability of Human Erythroviruses Present in Bone Marrow of Brazilian Patients with Various Parvovirus B19-Related Hematological Symptoms , 2006, Journal of Clinical Microbiology.

[10]  E. Delwart,et al.  Novel Parvovirus and Related Variant in Human Plasma , 2006, Emerging infectious diseases.

[11]  S. Modrow Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard? , 2006, Ernst Schering Research Foundation workshop.

[12]  A. Isa,et al.  Slow clearance of human parvovirus B19 viremia following acute infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Lefrère,et al.  Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. , 2005, Blood.

[14]  M. Tammi,et al.  Cloning of a human parvovirus by molecular screening of respiratory tract samples. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Kerr Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence. , 2005, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[16]  P. Simmonds,et al.  New DNA Viruses Identified in Patients with Acute Viral Infection Syndrome , 2005, Journal of Virology.

[17]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[18]  C. Tschöpe,et al.  High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction , 2005, Circulation.

[19]  A. Parsyan,et al.  Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor Samples , 2004, Journal of Virology.

[20]  T. Ohtsuka,et al.  Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin , 2004, The British journal of dermatology.

[21]  H. Gabbert,et al.  Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction , 2004, Zeitschrift für Kardiologie.

[22]  H. Figulla,et al.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy , 2004, Medical Microbiology and Immunology.

[23]  S. Modrow,et al.  Parvovirus B19 infection and autoimmune disease. , 2003, Autoimmunity reviews.

[24]  B. Maisch,et al.  Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. , 2003, Human pathology.

[25]  M. Söderlund-Venermo,et al.  A new parvovirus genotype persistent in human skin. , 2002, Virology.

[26]  Quang Tri Nguyen,et al.  Identification and characterization of a second novel human erythrovirus variant, A6. , 2002, Virology.

[27]  S. Laperche,et al.  Genetic Diversity within Human Erythroviruses: Identification of Three Genotypes , 2002, Journal of Virology.

[28]  S. Nikkari,et al.  Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[29]  M. Söderlund-Venermo,et al.  Persistence of human parvovirus B19 in human tissues. , 2002, Pathologie-biologie.

[30]  K. Zakrzewska,et al.  Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis , 2001, Journal of medical virology.

[31]  S. Koenig,et al.  Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. , 1999, The Journal of infectious diseases.

[32]  K. Hedman,et al.  Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders. , 1999, Scandinavian journal of infectious diseases.

[33]  K. Broliden,et al.  Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow. , 1999, Scandinavian journal of infectious diseases.

[34]  T. Pumarola Parvovirus B19 , 1999, Transfusion Medicine and Hemotherapy.

[35]  Quang Tri Nguyen,et al.  Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia , 1998, The Lancet.

[36]  G. Siegl,et al.  Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin , 1998, Journal of medical virology.

[37]  K. Zakrzewska,et al.  Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. , 1998, Virus research.

[38]  G. Siegl,et al.  Evidence for persistence of human parvovirus B19 DNA in bone marrow , 1997, Journal of medical virology.

[39]  K. Hedman,et al.  Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy , 1997, The Lancet.

[40]  S. Modrow,et al.  Sequence variability among different parvovirus B19 isolates. , 1996, The Journal of general virology.

[41]  M. Zerbini,et al.  Parvovirus B19 clearance from peripheral blood after acute infection. , 1995, The Journal of infectious diseases.

[42]  A. Reingold,et al.  Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.

[43]  A. Woolf Human parvovirus B19 and arthritis. , 1990, Behring Institute Mitteilungen.

[44]  N. Young,et al.  Chronic bone marrow failure due to persistent B19 parvovirus infection. , 1987, The New England journal of medicine.

[45]  J. Clewley,et al.  INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALIS , 1984, The Lancet.

[46]  M. Anderson,et al.  HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)? , 1983, The Lancet.

[47]  S. Jones,et al.  OUTBREAK OF APLASTIC CRISES IN SICKLE CELL ANAEMIA ASSOCIATED WITH PARVOVIRUS-LIKE AGENT , 1981, The Lancet.

[48]  P. Hochstein,et al.  POTENTIAL VARIANTS OF PHENYLKETONURIA , 1975, The Lancet.

[49]  Bender Ae Letter: Protein requirement. , 1974 .